Last reviewed · How we verify
valsartan+amlodipine combination, valsartan, amlodipine
valsartan+amlodipine combination, valsartan, amlodipine is a Small molecule drug developed by Novartis. It is currently in Phase 3 development.
At a glance
| Generic name | valsartan+amlodipine combination, valsartan, amlodipine |
|---|---|
| Sponsor | Novartis |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control (NA)
- Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy (PHASE3)
- Comparing Bisoprolol and Valsartan-Amlodipine for Hypertension (PHASE4)
- A Multicenter, Randomized, Double-Blind Phase 3 Trial of KDF1901 in Patients With Essential Hypertension (PHASE3)
- The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans (PHASE4)
- Role of ARNi in Ventricular Remodeling in Hypertensive LVH (PHASE2)
- Clinical Response of EXTOR (Amlodipine/Valsartan) in Newly Diagnosed Hypertensive Patients.
- Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- valsartan+amlodipine combination, valsartan, amlodipine CI brief — competitive landscape report
- valsartan+amlodipine combination, valsartan, amlodipine updates RSS · CI watch RSS
- Novartis portfolio CI
Frequently asked questions about valsartan+amlodipine combination, valsartan, amlodipine
What is valsartan+amlodipine combination, valsartan, amlodipine?
valsartan+amlodipine combination, valsartan, amlodipine is a Small molecule drug developed by Novartis.
Who makes valsartan+amlodipine combination, valsartan, amlodipine?
valsartan+amlodipine combination, valsartan, amlodipine is developed by Novartis (see full Novartis pipeline at /company/novartis).
What development phase is valsartan+amlodipine combination, valsartan, amlodipine in?
valsartan+amlodipine combination, valsartan, amlodipine is in Phase 3.